Видео с ютуба Event: Actrims 2026

Before The Headlines: ACTRIMS 2026 Explained

February 2026 Recall: Topics on Multiple Sclerosis

Immunic showcases Phase 2 data on vidofludimus calcium at ACTRIMS Forum

Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

2020 ECTRIMS/ACTRIMS Treatment & Research Update: Scott Silliman, MD: October 2020

HSCT versus high-efficacy therapies in multiple sclerosis: the BEAT-MS trial

HSCT in multiple sclerosis: current evidence and patient selection

Balancing Efficacy and Safety With MS Disease Modifying Therapies

Tom Friel: How to Network

The use of real-world data in the MedCP framework for MS research

Tal Arbel, PhD: Approaching Multiple Sclerosis with Machine Learning

Key remaining questions regarding HSCT in MS: procedure and effectiveness in treating PIRA

Agentic AI and the MedCP framework in MS research and beyond

Genetic biomarkers of MS susceptibility and the gut microbiome

Multiplex proteomics reveals a distinct inflammatory signature in RIS

Using machine learning predictions to design more efficient MS clinical trials

Predicting symptom onset in RIS using combined biomarker approaches

Applications of the MedCP framework: comorbidity mapping and identifying prodromal features of MS

World MS Day 2023: a message from ECTRIMS and its TRIMS partners worldwide

Welcome to ECTRIMS: Day 1